4 completed. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 4 | Completed 4 |
Follow Pseudomonas Aeruginosa: new trials by email Literature Review of Pseudomonas Aeruginosa trials Research Report on Pseudomonas Aeruginosa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection RSP-1502, Tobramycin inhalation solution - Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic | Phase 1 / Phase 2 | Completed | Respirion Pharmaceuticals Pty Ltd | 71 | 2024-04-01 | 2026-06-25 |
| Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis AP-PA02, Placebo - Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 1 / Phase 2 | Completed | Armata Pharmaceuticals, Inc. | 29 | 2020-12-22 | 2024-01-31 |
| Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa KB001, Placebo - Pseudomonas Aeruginosa, Ventilator Associated Pneumonia | Phase 1 / Phase 2 | Completed | Humanigen, Inc. | 36 | 2008-04-01 | 2009-07-31 |
| Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis Anti-pseudomonas IgY gargle - Cystic Fibrosis, Infection | Phase 1 / Phase 2 | Completed | Immunsystem AB | 14 | 2003-11-01 | 2016-09-01 |
Pseudomonas Infections (4) · Cystic Fibrosis (3) · Bronchiolitis Obliterans Syndrome (1) · Infections (1) · Pneumonia, Ventilator-Associated (1) · Recurrence (1) · Respiratory Tract Infections (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Negative Bacterial Infections (4) · Lung Diseases (4) · Respiratory Tract Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Genetic Diseases, Inborn (3) · Infant, Newborn, Diseases (3) · Infections (3) · Pancreatic Diseases (3) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bronchial Diseases (1)
Immunotherapy (1)
Armata Pharmaceuticals, Inc. (1) · Humanigen, Inc. (1) · Immunsystem AB (1) · Respirion Pharmaceuticals Pty Ltd (1)
United States (2) · Australia (1) · France (1) · Sweden (1)
Annika Hollsing, MD, PhD (1) · Mina Pastagia, MD, MS (1) · Prof. Jean Chastre (1)